Trial Profile
A Phase I Trial of Stereotactic Body Radiation Therapy Combined With Anti-PD-1 Antibody in Patients With Metastatic Triple Negative Breast Cancer
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Toripalimab (Primary)
- Indications Advanced breast cancer; Carcinoma; Triple negative breast cancer
- Focus Adverse reactions
- 17 May 2017 New trial record